imedecin.fr

La préménopause

Insomnie et cancer

Cancers du col de l’utérus, du vagin et de la vulve

Utilisation de l'airelle

Euthanasie ou droit à la souffrance

Etreinte immunologique

Le sommeil des enfants

Un nouveau centre d'imagerie Hight-Tech

L’épidémie de grippe devrait arriver à son terme

Hypertension et troubles cognitifs.

Imedecin.com

Hémorragies et défaillances circulatoires aigues

La douleur en sémiologie digestive

Endocrinologie - Œstrogène et progestérone

Anatomie descriptive du poumon

Endocrinologie des ovaires

Evolution des cancers en dehors des traitements

L'athérosclérose, athérome, athéromatose

Cryptosporidium parvum

Histologie des testicules

Trichinose ou Trichinellose

Le virus de l’hépatite B

Les corticosurrénales

Les médicaments anti-arythmiques

Les causes de l’ischémie

Diagnostic de la grossesse

Langue préférée :

Deutsch English Español
Français dansk suomi

 

Aktuell 3 Gäste und 0 registrierte Benutzer online.

Anmeldung

Sites imedecin

imedecin.org
Médecine et informatique
Médecine et mobilité




_HOME | _RSS

Medscape hematology oncology - Newseinträge


newsp.gif
There's No Place Like the "Medical Home"
Montag, 27. Oktober 2008, 05:43 Uhr - 1 Monat her   -  Presse spécialisée  -  Medscape hematology oncology
Darrell G. Kirch, MD, President and CEO, Association of American Medical Colleges, Washington, DC, shares his position on the medical home. The Medscape Journal of Medicine
Androgen-Receptor Antagonist for Advanced Prostate Cancer: 24-Week Data Available and Promising
Freitag, 24. Oktober 2008, 06:25 Uhr - 1 Monat, 1 Woche her   -  Presse spécialisée  -  Medscape hematology oncology
Preliminary data are available on a promising new treatment for patients with advanced prostate cancer who have failed standard hormonal therapy or chemotherapy. Medscape Medical News
Beyond a Dying Private Health Insurance Industry: A Hidden Solution in Plain View
Freitag, 24. Oktober 2008, 05:50 Uhr - 1 Monat, 1 Woche her   -  Presse spécialisée  -  Medscape hematology oncology
John Geyman, MD, Professor Emeritus of Family Medicine, University of Washington, explains what will happen when the American health insurance industry dies. The Medscape Journal of Medicine
Chest CT Recommended for Detecting Lung Metastasis in Head and Neck Cancer
Freitag, 24. Oktober 2008, 05:04 Uhr - 1 Monat, 1 Woche her   -  Presse spécialisée  -  Medscape hematology oncology
Computed tomography chest scanning is recommended for detecting lung metastasis in patients with head and neck squamous cell carcinoma, especially among high-risk patients during the 2-year period after initial diagnosis. Medscape Medical News
Socioeconomic Status Most Important Factor in NHL Survival
Donnerstag, 23. Oktober 2008, 10:27 Uhr - 1 Monat, 1 Woche her   -  Presse spécialisée  -  Medscape hematology oncology
After controlling for confounders such as socioeconomic status, treatment, tumor stage, there were no disparities in survival between black and white patients with non-Hodgkin's lymphoma. Medscape Medical News
A Patient With Ectopic Cortisol Production Derived From Malignant Testicular Masses
Donnerstag, 23. Oktober 2008, 09:00 Uhr - 1 Monat, 1 Woche her   -  Presse spécialisée  -  Medscape hematology oncology
A 65-year-old man presented to an oncology clinic with bilateral testicular masses, lower extremity edema, and cushingoid appearance. Nature Clinical Practice Endocrinology & Metabolism
Research on Rare Cancer in Children Takes Step Toward Treatment
Donnerstag, 23. Oktober 2008, 06:38 Uhr - 1 Monat, 1 Woche her   -  Presse spécialisée  -  Medscape hematology oncology
In a step toward developing a treatment for a childhood cancer, researchers have developed a molecular rationale for a targeted therapy for neuroblastoma. Medscape Medical News
Fecal Occult Blood Screening Does Reduce Death From Colon Cancer
Donnerstag, 23. Oktober 2008, 05:41 Uhr - 1 Monat, 1 Woche her   -  Presse spécialisée  -  Medscape hematology oncology
Dr. George Lundberg discusses how fecal blood occult screening does reduce death from colon cancer. The Medscape Journal of Medicine
Response to Cetuximab Predicted by KRAS Mutation in Colorectal Cancer
Mittwoch, 22. Oktober 2008, 13:59 Uhr - 1 Monat, 1 Woche her   -  Presse spécialisée  -  Medscape hematology oncology
Treatment with cetuximab is associated with increased median overall and progression-free survival among colorectal cancer patients with wild-type KRAS tumors. However, a significant survival benefit from cetuximab was not observed among patients with tumors that had KRAS mutations. Medscape Medical News
Asthma and Related Tissue Inflammation May Contribute to Cancer Metastasizing to Lung
Mittwoch, 22. Oktober 2008, 05:50 Uhr - 1 Monat, 1 Woche her   -  Presse spécialisée  -  Medscape hematology oncology
Lung-tissue inflammation related to asthma may help cancers metastasize to the lungs, but asthma treatment may be preventive. Medscape Medical News

    12345678910111213141516171819202122232425262728   >

News bereitgestellt von: Medscape Hematology-Oncology Headlines